Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jun;64(1):257-264.
doi: 10.1007/s10840-022-01207-y. Epub 2022 Apr 12.

A mobile app for improving the compliance with remote management of patients with cardiac implantable devices: a multicenter evaluation in clinical practice

Carlo Lavalle  1 , Michele Magnocavallo  2 , Alessia Bernardini  1 , Giampaolo Vetta  1 , Valter Bianchi  3 , Agostino Mattera  4 , Marco Valerio Mariani  1 , Ernesto Ammendola  5 , Giuseppe Busacca  6 , Agostino Piro  1 , Carmen Adduci  7 , Leonardo Calò  8 , Luca Panchetti  9 , Stefano Viani  10 , Antonio Rapacciuolo  11 , Giampaolo Sanna  12 , Giulio Molon  13 , Fabio Quartieri  14 , Rita Di Rosa  15 , Monica Campari  16 , Sergio Valsecchi  16 , Antonio D'Onofrio  3
Affiliations
Review

A mobile app for improving the compliance with remote management of patients with cardiac implantable devices: a multicenter evaluation in clinical practice

Carlo Lavalle et al. J Interv Card Electrophysiol. 2022 Jun.

Abstract

Background: The remote device management (RM) is recommended for patients with cardiac implantable electronic devices (CIEDs). RM underutilization is frequently driven by the lack of correct system activation. The MyLATITUDE Patient App (Boston Scientific) has been developed to encourage patient compliance with RM by providing information on communicator setup, troubleshooting, and connection status of the communicator.

Methods: At 14 centers, patients with CIEDs were invited to download and install the App on a mobile device. After 3 months, patients were asked to complete an ad hoc questionnaire to evaluate their experience.

Results: The App was proposed to 242 consecutive patients: 81 before RM activation, and 161 during follow-up. The App was successfully installed by 177 (73%) patients. The time required for activation of the communicator and the need for additional support were similar between patients who followed the indications provided by the App and those who underwent standard in-clinic training. During follow-up, notifications of lack of connection were received by 20 (11%) patients and missed transmission by 22 (12%). The median time from notification to resolution was 2 days. After 3 months, 175 (99%) communicators of the 177 patients who installed the App were in "Monitored" status versus 113 (94%) of 120 patients without the App installed (p=0.033). The use of the app made 84% of patients feel reassured.

Conclusions: The App was well accepted by CIED patients and offered support for communicator management and installation. Its use enabled patients to remain connected with greater continuity during follow-up.

Keywords: Cardiac implantable electronic device; Follow-up; Mobile app; Remote monitoring.

PubMed Disclaimer

Conflict of interest statement

M. Campari and S. Valsecchi are employees of Boston Scientific. The other authors report no conflicts.

Figures

Fig. 1
Fig. 1
The MyLATITUDE™ Patient App enables patients to independently obtain instruction and information on their LATITUDE™ NXT Communicator and implanted device
See this image and copyright information in PMC

References

    1. Glikson M, Nielsen JC, Kronborg MB, et al. ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Eur Heart J. 2021; 2021:ehab364. - PubMed
    1. Slotwiner D, Varma N, Akar JG, et al. HRS Expert Consensus Statement on remote interrogation and monitoring for cardiovascular implantable electronic devices. Heart Rhythm. 2015;12:e69–e100. doi: 10.1016/j.hrthm.2015.05.008. - DOI - PubMed
    1. Mabo P, Victor F, Bazin P, et al. A randomized trial of long-term remote monitoring of pacemaker recipients (The COMPAS trial) Eur Heart J. 2012;33:1105–1111. doi: 10.1093/eurheartj/ehr419. - DOI - PMC - PubMed
    1. García-Fernández FJ, Osca Asensi J, Romero R, et al. Safety and efficiency of a common and simplified protocol for pacemaker and defibrillator surveillance based on remote monitoring only: a long-term randomized trial (RM-ALONE) Eur Heart J. 2019;40:1837–1846. doi: 10.1093/eurheartj/ehz067. - DOI - PMC - PubMed
    1. Parthiban N, Esterman A, Mahajan R, et al. Remote monitoring of implantable cardioverter-defibrillators. J Am Coll Cardiol. 2015;65:2591–2600. doi: 10.1016/j.jacc.2015.04.029. - DOI - PubMed